<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> are <z:hpo ids='HP_0011010'>chronic</z:hpo> relapsing immune mediated disorders that results from an aberrant response to gut <z:chebi fb="2" ids="8069">luminal</z:chebi> antigen in genetically susceptible host </plain></SENT>
<SENT sid="1" pm="."><plain>The adaptive immune response that is then triggered was widely considered to be a T-helper-1 mediated condition in <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and T-helper-2 mediated condition in <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Recent studies in animal models, genome wide association, and basic science has provided important insights in in the immunopathogenesis of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>, one of which was the characterization of the interleukin-23/Th-17 axis </plain></SENT>
</text></document>